🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
NMDA antagonist drugs have increasingly been demonstrated to reduce symptom...
Status
Unknown
Location
Research Site, Birmingham
Start Date
2019-12-01
Trial ID
NCT03396068
Treatments Being Tested
Subnormal level of Glutamate+Glutamine (Glx) in the Anterior Cingulate Cort...
Status
Completed
Location
New York State Psychiatric Institute
Start Date
2018-11-01
Trial ID
NCT03402152
Treatments Being Tested
The goal of this clinical study is to test NRX101 in participants with comp...
Status
Unknown
Location
Multiple Locations
Start Date
2024-03-31
Trial ID
NCT06128213
Treatments Being Tested
NeuroRx is developing NRX-101, a fixed-dose combination oral capsule compos...
Status
Completed
Location
Research Site, Birmingham
Start Date
2018-01-15
Trial ID
NCT02974010
NMDA antagonist drugs have shown to reduce symptoms of depression and suici...
Status
Completed
Location
Science 37
Start Date
2022-05-12
Trial ID
NCT03395392
Treatments Being Tested